Total Payments
$155,990
2023 Payments
$546.91
Companies
36
Transactions
233
Payment Breakdown by Category
Consulting$107,669 (69.0%)
Travel$23,242 (14.9%)
Other$18,805 (12.1%)
Food & Beverage$6,223 (4.0%)
Education$51.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $107,669 | 44 | 69.0% |
| Travel and Lodging | $23,242 | 83 | 14.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,736 | 6 | 10.1% |
| Food and Beverage | $6,223 | 96 | 4.0% |
| Honoraria | $3,069 | 2 | 2.0% |
| Education | $51.50 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22,281 | 37 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $10,874 | 28 | $0 (2019) |
| Sight Sciences, Inc. | $9,450 | 7 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $8,726 | 17 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $7,448 | 19 | $0 (2018) |
| Amgen Inc. | $7,166 | 8 | $0 (2018) |
| Celgene Corporation | $6,791 | 9 | $0 (2019) |
| Eli Lilly and Company | $6,654 | 6 | $0 (2017) |
| GENZYME CORPORATION | $6,462 | 1 | $0 (2021) |
| Mallinckrodt LLC | $6,304 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $546.91 | 3 | GE HealthCare ($286.91) |
| 2022 | $13,095 | 8 | PFIZER INC. ($4,440) |
| 2021 | $9,502 | 3 | GENZYME CORPORATION ($6,462) |
| 2020 | $11,291 | 11 | Sight Sciences, Inc. ($4,550) |
| 2019 | $47,217 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,734) |
| 2018 | $34,041 | 58 | Amgen Inc. ($7,166) |
| 2017 | $40,296 | 72 | Bayer HealthCare Pharmaceuticals Inc. ($8,726) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2023 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $260.00 | General |
| Category: Neurology | ||||||
| 04/17/2023 | GE HealthCare | — | Travel and Lodging | Cash or cash equivalent | $237.11 | General |
| 04/17/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $49.80 | General |
| 12/16/2022 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,220.00 | General |
| 11/24/2022 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,220.00 | General |
| 11/23/2022 | EISAI INC. | — | Consulting Fee | Cash or cash equivalent | $3,120.00 | General |
| 07/11/2022 | Johnson & Johnson Health Care Systems Inc. | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 06/20/2022 | Novo Nordisk AS | Tresiba (Drug) | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| Category: Diabetes | ||||||
| 03/17/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 03/16/2022 | GE HealthCare | — | Travel and Lodging | Cash or cash equivalent | $301.12 | General |
| 03/16/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $43.87 | General |
| 08/11/2021 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Ophthalmology | ||||||
| 08/04/2021 | Astellas Pharma Global Development | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $1,640.00 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $6,462.00 | General |
| Category: Immunology | ||||||
| 12/23/2020 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Neuroscience | ||||||
| 11/20/2020 | CSL Behring | — | Honoraria | Cash or cash equivalent | $568.75 | General |
| 11/18/2020 | Sight Sciences, Inc. | OMNI (Device) | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: Ophthalmology | ||||||
| 11/18/2020 | Sight Sciences, Inc. | OMNI (Device) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: Ophthalmology | ||||||
| 09/16/2020 | Sight Sciences, Inc. | OMNI (Device) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Ophthalmology | ||||||
| 09/02/2020 | Sight Sciences, Inc. | OMNI (Device) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Ophthalmology | ||||||
| 06/10/2020 | Sight Sciences, Inc. | OMNI (Device) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Ophthalmology | ||||||
| 02/05/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $261.97 | General |
| 01/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $3,785.00 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: RESPIRATORY | ||||||
| 01/08/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
About Dr. Fredrick May, MD
Dr. Fredrick May, MD is a Pediatrics healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1659557007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fredrick May, MD has received a total of $155,990 in payments from pharmaceutical and medical device companies, with $546.91 received in 2023. These payments were reported across 233 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($107,669).
Ad
Practice Information
- Specialty Pediatrics
- Location Indianapolis, IN
- Active Since 01/16/2008
- Last Updated 04/30/2017
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659557007
Products in Payments
- OFEV (Drug) $12,890
- OMNI (Device) $8,050
- IMLYGIC (Biological) $7,166
- BB-2121 (Drug) $6,746
- DUPIXENT (Biological) $6,462
- ACTHAR (Biological) $6,304
- DUPIXENT DUPILUMAB INJECTION (Biological) $4,889
- Stravix (Biological) $4,237
- FASENRA (Drug) $4,017
- BEOVU (Drug) $3,896
- DASOTRALINE (Drug) $3,869
- Axumin (Drug) $3,691
- Exogen (Device) $3,593
- Dexcom G5 Mobile CGM System (Device) $3,460
- IMFINZI (Drug) $3,233
- Yescarta (Drug) $2,807
- NOURIANZ (Drug) $2,202
- SPRAVATO (Drug) $1,950
- TECVAYLI (Biological) $1,950
- XOSPATA (Drug) $1,640
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Indianapolis
Sanjay Ahuja, Md, MD
Pediatrics — Payments: $200,890
Pediatrics $200,890
Marissa Just, M.d, M.D
Pediatrics — Payments: $54,221
Pediatrics $54,221
Mrs. Jori Matushek, Np, NP
Pediatrics — Payments: $39,234
Pediatrics $39,234
Darlene House, Md, MD
Pediatrics — Payments: $17,100
Pediatrics $17,100
Mary Stuy, M.d, M.D
Pediatrics — Payments: $15,352
Pediatrics $15,352
Christa Goebes, Apn, APN
Pediatrics — Payments: $14,184
Pediatrics $14,184